Bausch Health (BHC) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
19 May, 2026Opening remarks and agenda
Meeting commenced with a welcome from the CEO, who introduced the board nominees and executive team, and confirmed the presence of the independent auditor representative.
Confirmation of proper notice, quorum, and appointment of a scrutineer for the meeting.
Board and executive committee updates
Ten director nominees were introduced, including new and continuing members with diverse backgrounds in finance, pharmaceuticals, and law.
Shareholder proposals
Three items were presented for shareholder voting: election of directors, advisory vote on executive compensation, and appointment of auditors.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Bausch Health
- Sustained growth, robust liquidity, and strategic flexibility underpin future value creation.BHC
Barclays 30th Annual Leveraged Finance Conference 202621 May 2026 - Sustained growth, China expansion, and BLCO monetization drive strategic priorities.BHCRBC Capital Markets Global Healthcare Conference 202620 May 2026
- Double-digit revenue and EBITDA growth, but a $1.43B goodwill impairment drove a net loss.BHCQ1 202630 Apr 2026
- 11th straight quarter of revenue and EBITDA growth, with strong outlook and lower net debt.BHCQ4 202513 Apr 2026
- Board recommends approval of all proposals, with strong focus on pay-for-performance and ESG.BHCProxy filing8 Apr 2026
- Director elections, executive pay, and auditor appointment up for virtual shareholder vote.BHCProxy filing8 Apr 2026
- Q2 2024 revenue up 11% to $2.40B, adjusted EBITDA up 10%, and debt reduced by $360M.BHCQ2 20242 Feb 2026
- Q3 revenue up 12%, Adjusted EBITDA up 10%, guidance raised, and all segments grew.BHCQ3 202417 Jan 2026
- Strong 2024 results and 2025 growth outlook driven by GI, aesthetics, and neuroscience franchises.BHC44th Annual J.P. Morgan Healthcare Conference15 Jan 2026